AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 294: F1116-F1128, 2008. First published March 12, 2008; doi:10.1152/ajprenal.00142.2007
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
294/5/F1116    most recent
00142.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Elberg, G.
Right arrow Articles by Turman, M. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elberg, G.
Right arrow Articles by Turman, M. A.

MKL1 mediates TGF-β1-induced {alpha}-smooth muscle actin expression in human renal epithelial cells

Gerard Elberg, Lijuan Chen, Dorit Elberg, Michael D. Chan, Charlotte J. Logan, and Martin A. Turman

Section of Nephrology, Department of Pediatrics, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Submitted 27 March 2007 ; accepted in final form 6 March 2008

Transforming growth factor-β1 (TGF-β1) is known to induce epithelial-mesenchymal transition in the kidney, a process involved in tubulointerstitial fibrosis. We hypothesized that a coactivator of the serum response factor (SRF), megakaryoblastic leukemia factor-1 (MKL1), stimulates {alpha}-smooth muscle actin ({alpha}-SMA) transcription in primary cultures of renal tubular epithelial cells (RTC), which convert into myofibroblasts on treatment with TGF-β1. Herein, we study the effect of MKL1 expression on {alpha}-SMA in these cells. We demonstrate that TGF-β1 stimulation of {alpha}-SMA transcription is mediated through CC(A/T)6-rich GG elements known to bind to SRF. These elements also mediate the MKL1 effect that dramatically activates {alpha}-SMA transcription in serum-free media. MKL1 fused to green fluorescent protein localizes to the nucleus and induces {alpha}-SMA expression regardless of treatment with TGF-β1. Using proteasome inhibitors, we also demonstrate that the proteolytic ubiquitin pathway regulates MKL1 expression. These data indicate that MKL1 overexpression is sufficient to induce {alpha}-SMA expression. Inhibition of endogenous expression of MKL1 by small interfering RNA abolishes TGF-β1 stimulation of {alpha}-SMA expression. Therefore, MKL1 is also absolutely required for TGF-β1 stimulation of {alpha}-SMA expression. Western blot and immunofluorescence analysis show that overexpressed and endogenous MKL1 are located in the nucleus in non-stimulated RTC. Chromatin immunoprecipitation assay demonstrates that TGF-β1 induces binding of endogenous SRF and MKL1 to the {alpha}-SMA promoter in chromatin. Since MKL1 constitutes a potent factor regulating {alpha}-SMA expression, modulation of endogenous MKL1 expression or activity may have a profound effect on myofibroblast formation and function in the kidney.

epithelial-mesenchymal transition; myocardin; ubiquitin; transcription; myofibroblast



Address for reprint requests and other correspondence: G. Elberg, Dept. of Pediatrics/Nephrology, The Univ. of Oklahoma Health Sciences Center, 940 N.E. 13th St., 2B2309, Oklahoma City, OK (e-mail: gerard-elberg{at}ouhsc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.